Claim(permalink)
The publication of a Pfizer document in 2022 is the first time that the public have been able to view data from its clinical trials that was submitted for the Covid-19 vaccine’s approval.
✓full-fact rating: not verifiable; published on 2022-03-22
Factors
veracity
not verifiable
Political Leaning
left political leaning
Sentiment
neutral sentiment
Date published
2022-03-22
Entities
MarsPhases of clinical researchCausalityDaily ExpressAdverse eventMedicines and Healthcare products Regulatory AgencyClinical trialNew EnglandMedicationFood and Drug AdministrationCenters for Disease Control and PreventionPfizerUnited KingdomFull FactBenefit shortfallLinux.conf.au